Avacta Group's pre|CISION® Platform Earns R&D Achievement Award at Pharma Industry Awards UK 2026

Avacta Group's pre|CISION® Platform Earns R&D Achievement Award at Pharma Industry Awards UK 2026 →

Avacta Group plc (AIM: AVCT), a clinical-stage life sciences firm specialising in targeted oncology therapies, has revealed that its proprietary pre|CISION® platform received the Research and Development Achievement Award at the Pharma Indu…